← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 31, 2020Last known activity
Jan 31, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 3 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (8)
- NCT05464940Overall official - principal investigatorN/AJan 31, 2023
- NCT05464940Lead sponsorN/AJan 31, 2023
- NCT05575999Overall official - principal investigatorPhase 1Jan 31, 2023
- NCT05575999Lead sponsorPhase 1Jan 31, 2023
- NCT05464940OfficialN/AJan 31, 2023
- NCT05575999OfficialPhase 1Jan 31, 2023
- NCT04473807Overall official - principal investigatorPhase 4Aug 31, 2020
- NCT04473807Lead sponsorPhase 4Aug 31, 2020
Details
- Last known activity
- Jan 31, 2023